The B- part of the cases focuses on the outcome of the lawsuit against the South African government. But the demands from the NGOs keep on coming and Garnier, the CEO of GSK, is faced with some tough decisions to make. Should he allow licensing? How should he deal with parallel importation?
GlaxoSmithKline and AIDS drugs in South Africa (A): The fight for lives and profits
Summary
The case describes the interactions among pharmaceutical companies, NGOs, and governments in the context of the AIDS epidemic in South Africa. Oxfa...
Reference
IMD-3-1496
Copyright
©2005
Copyright owner
IMD Copyright
Organization
GlaxoSmithKline
Industry
Healthcare, Pharmaceuticals
Available Languages
English
Contact
Research Information & Knowledge Hub for additional information on IMD publications
GlaxoSmithKline and AIDS drugs in South Africa (B): The settlement
Summary
The B- part of the cases focuses on the outcome of the lawsuit against the South African government. But the demands from the NGOs keep on coming a...
Reference
IMD-3-1497
Copyright
©2005
Copyright owner
IMD Copyright
Organization
GlaxoSmithKline
Industry
Healthcare, Pharmaceuticals
Available Languages
English
Contact
Research Information & Knowledge Hub for additional information on IMD publications
GlaxoSmithKline and AIDS drugs in South Africa (C): The fight goes on
Summary
The C- part of the cases focuses on the actions GSK had to take being pressured by the NGOs. The company had been defeated and it agreed to several...
Reference
IMD-3-1498
Copyright
©2005
Copyright owner
IMD Copyright
Organization
GlaxoSmithKline
Industry
Healthcare, Pharmaceuticals
Available Languages
English
Contact
Research Information & Knowledge Hub for additional information on IMD publications
GlaxoSmithKline and AIDS drugs in South Africa (D): US developments
Summary
The D- case focuses on the developments in the US markets. The AIDS drugs issue that had begun in South Africa was beginning to feed a "perfect sto...
Reference
IMD-3-1499
Copyright
©2005
Copyright owner
IMD Copyright
Organization
GlaxoSmithKline
Industry
Healthcare, Pharmaceuticals
Available Languages
English
Contact
Research Information & Knowledge Hub for additional information on IMD publications